Mark Zimmerman, MD

Generalizability of Placebo-Controlled Studies of Antidepressants

December 28, 2016

This commentary by Mark Zimmerman, MD, discusses the article "Generalizability of Neuroimaging Studies in 5 Common Psychiatric Disorders Based on the National Epidemiologic Survey on Alcohol and Related Conditions...

Mark Zimmerman

Commentary

Does the Adequacy of Clinicians' Diagnostic Practice in Routine Clinical Settings Matter?

July 22, 2015

Mark Zimmerman

Original Research

A Clinically Useful Self-Report Measure of the DSM-5 Anxious Distress Specifier for Major Depressive Disorder

April 29, 2014

Mark Zimmerman , Iwona Chelminski , Diane Young , et al

Original Research

Speaking a More Consistent Language When Discussing Severe Depression: A Calibration Study of 3 Self-Report Measures of Depressive Symptoms

December 10, 2013

Mark Zimmerman , Michael Friedman , Naureen Attiullah , et al

Article

Bipolar II Depression vs. MDD

September 16, 2013

Read an article distinguishing between bipolar II depression and MDD with comorbid borderline personality disorder, including family history variables.

Mark Zimmerman , Iwona Chelminski , Jennifer H. Martinez , et al

Original Research

"Subthreshold" Depression: Is the Distinction Between Depressive Disorder Not Otherwise Specified and Adjustment Disorder Valid?

May 15, 2013

Mark Zimmerman , Iwona Chelminski , Jennifer H. Martinez , et al

Original Research

Prevalence of Attenuated Psychotic Symptoms and Their Relationship With DSM-IV Diagnoses in a General Psychiatric Outpatient Clinic

October 2, 2012

Mark Zimmerman , Brandon A. Gaudiano

ASCP Corner

Discordance Between Researchers and Patients in Defining Remission From Depression

September 15, 2012

Mark Zimmerman

Original Research

How Can We Use Depression Severity to Guide Treatment Selection When Measures of Depression Categorize Patients Differently?

September 4, 2012

Mark Zimmerman , Michael Friedman , Naureen Attiullah , et al

Original Research

Why Do Some Depressed Outpatients Who Are in Remission According to the Hamilton Depression Rating Scale Not Consider Themselves to Be in Remission?

April 17, 2012

Mark Zimmerman , Michael Friedman , Naureen Attiullah , et al

Commentary

Would Broadening the Diagnostic Criteria for Bipolar Disorder Do More Harm Than Good? Implications From Longitudinal Studies of Subthreshold Conditions

April 15, 2012

Mark Zimmerman

Original Research

Impact of Deleting 5 DSM-IV Personality Disorders on Prevalence, Comorbidity, and the Association Between Personality Disorder Pathology and Psychosocial Morbidity

January 24, 2012

Mark Zimmerman , Iwona Chelminski , Diane Young , et al

Generalizability of Placebo-Controlled Studies of Antidepressants

Does the Adequacy of Clinicians' Diagnostic Practice in Routine Clinical Settings Matter?

A Clinically Useful Self-Report Measure of the DSM-5 Anxious Distress Specifier for Major Depressive Disorder

Speaking a More Consistent Language When Discussing Severe Depression: A Calibration Study of 3 Self-Report Measures of Depressive Symptoms

Bipolar II Depression vs. MDD

"Subthreshold" Depression: Is the Distinction Between Depressive Disorder Not Otherwise Specified and Adjustment Disorder Valid?

Prevalence of Attenuated Psychotic Symptoms and Their Relationship With DSM-IV Diagnoses in a General Psychiatric Outpatient Clinic

Discordance Between Researchers and Patients in Defining Remission From Depression

How Can We Use Depression Severity to Guide Treatment Selection When Measures of Depression Categorize Patients Differently?

Why Do Some Depressed Outpatients Who Are in Remission According to the Hamilton Depression Rating Scale Not Consider Themselves to Be in Remission?

Would Broadening the Diagnostic Criteria for Bipolar Disorder Do More Harm Than Good? Implications From Longitudinal Studies of Subthreshold Conditions

Impact of Deleting 5 DSM-IV Personality Disorders on Prevalence, Comorbidity, and the Association Between Personality Disorder Pathology and Psychosocial Morbidity

ELSEWHERE:

FOLLOW US:

Mark Zimmerman, MD

Generalizability of Placebo-Controlled Studies of Antidepressants

Does the Adequacy of Clinicians' Diagnostic Practice in Routine Clinical Settings Matter?

A Clinically Useful Self-Report Measure of the DSM-5 Anxious Distress Specifier for Major Depressive Disorder

Speaking a More Consistent Language When Discussing Severe Depression: A Calibration Study of 3 Self-Report Measures of Depressive Symptoms

Bipolar II Depression vs. MDD

"Subthreshold" Depression: Is the Distinction Between Depressive Disorder Not Otherwise Specified and Adjustment Disorder Valid?

Prevalence of Attenuated Psychotic Symptoms and Their Relationship With DSM-IV Diagnoses in a General Psychiatric Outpatient Clinic

Discordance Between Researchers and Patients in Defining Remission From Depression

How Can We Use Depression Severity to Guide Treatment Selection When Measures of Depression Categorize Patients Differently?

Why Do Some Depressed Outpatients Who Are in Remission According to the Hamilton Depression Rating Scale Not Consider Themselves to Be in Remission?

Would Broadening the Diagnostic Criteria for Bipolar Disorder Do More Harm Than Good? Implications From Longitudinal Studies of Subthreshold Conditions

Impact of Deleting 5 DSM-IV Personality Disorders on Prevalence, Comorbidity, and the Association Between Personality Disorder Pathology and Psychosocial Morbidity

Watch the New PsychCase360

Subscribe to readmore articles

Subscribe to read
more articles